Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Antiaging Quantum Living Inc AAQL

Antiaging Quantum Living Inc. is an investment holding company. It focuses on Website development, maintenance and online business advertisement. Its primary business operations are conducted through its subsidiaries AAQL Inc., AAQL HK Limited, Antiaging Doctor Hangzhou Holding LTD (Dao Ling Doctor Hangzhou), Dao Ling Doctor (Zhejiang) Health Management Limited (Dao Ling Doctor Zhejiang), and... see more

Recent & Breaking News (OTCPK:AAQL)

Research Report Coverage on Biotech Stocks -- Halozyme Therapeutics, Achillion Pharma, Aegerion Pharma and Chimerix

PR Newswire August 23, 2016

Achillion Announces Upcoming Presentation of Interim Phase 2a Results From the Janssen Sponsored Trial of Odalasvir, AL-335 and Simeprevir at the European Association for the Study of the Liver (EASL) Special Conference

GlobeNewswire August 11, 2016

Achillion to Present at the 2016 Wedbush PacGrow Healthcare Conference

GlobeNewswire August 9, 2016

Achillion Reports Second Quarter 2016 Financial Results

GlobeNewswire August 4, 2016

The Market In 5 Minutes: Bank Of England Keeps Interest Rates On Hold

Benzinga.com  July 14, 2016

Achillion Presents Interim Phase 1 Results for ACH-4471, a Novel Orally-Administered Factor D Inhibitor, at the 21st Congress of the European Hematology Association

GlobeNewswire June 10, 2016

Biotechnology Equities Technical Notes -- Grifols, Achillion Pharma, Jazz Pharma, and Puma Biotechnology

PR Newswire June 8, 2016

Achillion to Present at Three Upcoming Investor Conferences

GlobeNewswire June 1, 2016

Achillion Announces Acceptance of Late Breaking Abstract for ACH-4471 at the 21st Congress of the European Hematology Association

GlobeNewswire May 19, 2016

Achillion Reports First Quarter 2016 Financial Results and Provides Update on Clinical Programs

GlobeNewswire May 3, 2016

Achillion to Present at the Deutsche Bank 41st Annual Health Care Conference

GlobeNewswire April 28, 2016

Achillion to Present at Two Upcoming Investor Conferences

GlobeNewswire March 3, 2016

Achillion Reports 2015 Fourth Quarter and Year-End Financial Results

GlobeNewswire February 25, 2016

Achillion Initiates Phase 1 Study of ACH-4471, First Orally-Administered Small Molecule Complement Factor D Inhibitor

GlobeNewswire February 11, 2016

Achillion to Present at the Leerink Partners 5th Annual Global Healthcare Conference

GlobeNewswire February 8, 2016

Achillion Announces Appointments of Martha Manning as General Counsel and Amy Jennings as Head of Regulatory Affairs

GlobeNewswire February 3, 2016

Achillion Appoints Dr. Joel Barrish as Chief Scientific Officer

GlobeNewswire January 4, 2016

Today's Market Driven by Key Factors -- Research on Tumi Holdings, Meritor, Achillion Pharmaceuticals and Geron

Accesswire December 21, 2015

Achillion Appoints Dr. Frank Verwiel to Board of Directors

GlobeNewswire December 16, 2015

Where Opportunity is Found - Free Research on St. Joe Co, Tumi Holdings, Meritor and Achillion Pharmaceuticals

Accesswire December 10, 2015